VAG
MRNA icon

VisionPoint Advisory Group’s Moderna MRNA Stock Holding History

VisionPoint Advisory Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,920
Closed -$644K – 106
2021
Q1 		$644K Sell
4,920
-518
-10% -$75.1K 0.31% 72
2020
Q4 		$568K Buy
5,438
+1,955
+56% +$198K 0.29% 73
2020
Q3 		$246K Buy
3,483
+543
+18% +$37.9K 0.11% 107
2020
Q2 		$215K Buy
+2,940
New +$161K 0.09% 102

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $12.5B AUM 54.4% 1-Year Est. Return

VisionPoint Advisory Group's MRNA Position: Q2 2021 in Review

VisionPoint Advisory Group sold out of Moderna (MRNA) in Q2 2021, closing a stake of 4,920 shares — an estimated $644K sold.

VisionPoint Advisory Group first reported a position in MRNA in Q2 2020 and held it in 4 quarters. The position peaked at $644K in Q1 2021. 903 funds tracked by Wall St. Rank hold MRNA as of Q2 2021.

  • VisionPoint Advisory Group reported no remaining Moderna position as of Q2 2021 after selling out during the quarter.
  • VisionPoint Advisory Group sold 4,920 Moderna shares in Q2 2021, an estimated $644K.
  • VisionPoint Advisory Group first reported a position in Moderna in Q2 2020 and held it in 4 quarters.
  • VisionPoint Advisory Group's Moderna position peaked at $644K in Q1 2021.
  • 903 funds tracked by Wall St. Rank held Moderna as of Q2 2021.

Based on VisionPoint Advisory Group's 13F filing for Q2 2021, filed 10 Aug 2021.